Breathtec Biomedical, Inc
Breathtec Biomedical, Inc. is a clinical-stage drug development company based in Gainesville, FL, focusing on innovative therapeutic applications for unmet medical needs. The company employs a drug repurposing model that allows for the efficient discovery of new uses for established drugs, minimizing capital investment and reducing developmental risks.
Breathtec's current research pipeline includes NP-251 Repirinast and AP-188 N-N-Dimethyltryptamine (DMT), targeting chronic kidney disease and potential treatments for stroke and traumatic brain injury, respectively. Through their subsidiary, Algernon NeuroScience, the company is advancing new clinical trials and initiatives, including the establishment of medical clinics utilizing advanced PET brain scan technology for early-stage Alzheimer's detection.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
